Acasti Pharma reported $57.7M in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Acasti Pharma USD 57.7M 7.62M Sep/2026
Addus HomeCare USD 1.45B 6.3M Sep/2026
Amarin USD 634.08M 9.72M Sep/2026
Cassava Sciences USD 100.06M 3.84M Sep/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Option Care Health USD 3.48B 97.49M Sep/2026
Organigram Holdings CAD 820.26M 298.95M Jun/2026
Tilray USD 2.1B 15.95M Sep/2025